Targeting RNA modifications and hypoxia signalling pathways to eliminate cancer stem cells
How to eliminate cancer stem cells through targeting RNA modifications and hypoxia signalling pathways? Find out at the next IMol Science Club seminar on April 5th where we will be joined by Kamil Kranc from Barts Cancer Institute of Queen Mary University of London!
Kamil is the Deputy Lead of the Centre for Haemato-Oncology at Barts Cancer Institute. His current research focuses on the significance of RNA modifications and hypoxia pathways in normal and malignant haematopoiesis. The central aim of Kamil’s laboratory is to understand the biology of leukaemic stem cells and identify therapeutic targets to specifically eradicate them, thus discovering novel and efficient therapies. His laboratory also aims to understand haematopoietic stem cell biology with the hope to harness this knowledge to expand these stem cells for therapeutic purposes.
April 5th 2023, 2 PM CET IMol conference room, Flisa street no 6, Warsaw Kamil Kranc Targeting RNA modifications and hypoxia signalling pathways to eliminate cancer stem cells in acute myeloid leukaemia
The seminar is open to the public. More information and registration form: https://www.imol.institute/imol-science-club